Geron | GERN - Zinsaufwendungen Für Schuld





Zinsaufwendungen Für Schuld Veränderung Datum
Amgen USD 657M 4M 2026-03
Bio Techne USD 2.17M 9K 2025-12
Cassava Sciences USD 108.37M 396.06M 2026-03
Cytokinetics USD 33.34M 3M 2026-03
Esperion Therapeutics USD 22.64M 585K 2025-12
Exelixis USD 23.4M 3.9M 2023-09
Genmab DKK 10M 27M 2025-12
Geron USD 7.15M 150K 2026-03
Gilead Sciences USD 240M 15M 2026-03
Incyte USD 569K 13K 2026-03
MacroGenics USD 3.34M 2.54M 2025-09
Novartis USD 343M 39M 2026-03
Novavax USD 5.82M 342K 2025-12